Polypid Stock Performance
| PYPD Stock | USD 2.51 0.24 8.73% |
The company holds a Beta of 0.74, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PolyPid's returns are expected to increase less than the market. However, during the bear market, the loss of holding PolyPid is expected to be smaller as well. At this point, PolyPid has a negative expected return of -0.21%. Please make sure to check PolyPid's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if PolyPid performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days PolyPid has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (8.73) | Five Day Return (8.39) | Year To Date Return (17.70) | Ten Year Return (99.56) | All Time Return (99.56) |
Last Split Factor 1:30 | Last Split Date 2023-09-21 |
1 | PolyPid Regains Nasdaq Compliance with Private Placement Boost - TipRanks | 01/17/2025 |
2 | Rodman Renshaw sets PolyPid stock at Buy with 13 target - Investing.com | 01/28/2025 |
3 | Major Surgical Innovation Updates Expected PolyPid Sets Critical Q4 Earnings Date - StockTitan | 01/29/2025 |
4 | PolyPid GAAP EPS of -1.13 misses by 0.31 | 02/12/2025 |
5 | PolyPid Ltd Q4 2024 Earnings Call Highlights Strategic Advances Amid Rising RD Costs | 02/13/2025 |
6 | PolyPid to Participate in the 37th Annual ROTH Conference | 03/03/2025 |
7 | PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX for the Prevention of Abdominal Colorectal Surgical Site Infections | 03/11/2025 |
8 | PolyPid Ltd. Short Interest Update | 03/27/2025 |
| Begin Period Cash Flow | 5.7 M |
PolyPid |
PolyPid Relative Risk vs. Return Landscape
If you would invest 300.00 in PolyPid on January 5, 2025 and sell it today you would lose (49.00) from holding PolyPid or give up 16.33% of portfolio value over 90 days. PolyPid is currently does not generate positive expected returns and assumes 3.9606% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than PolyPid, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PolyPid Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyPid's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PolyPid, and traders can use it to determine the average amount a PolyPid's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.053
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PYPD |
Estimated Market Risk
| 3.96 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PolyPid is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PolyPid by adding PolyPid to a well-diversified portfolio.
PolyPid Fundamentals Growth
PolyPid Stock prices reflect investors' perceptions of the future prospects and financial health of PolyPid, and PolyPid fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PolyPid Stock performance.
| Return On Equity | -10.39 | ||||
| Return On Asset | -0.86 | ||||
| Current Valuation | 19.56 M | ||||
| Shares Outstanding | 10.19 M | ||||
| Price To Book | 3.33 X | ||||
| EBITDA | (26.41 M) | ||||
| Net Income | (29.02 M) | ||||
| Cash And Equivalents | 23.78 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 9.62 M | ||||
| Debt To Equity | 0.47 % | ||||
| Current Ratio | 2.87 X | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | (21.96 M) | ||||
| Earnings Per Share | (4.91) X | ||||
| Market Capitalization | 25.58 M | ||||
| Total Asset | 25.22 M | ||||
| Retained Earnings | (267.33 M) | ||||
| Working Capital | 3.89 M | ||||
About PolyPid Performance
By analyzing PolyPid's fundamental ratios, stakeholders can gain valuable insights into PolyPid's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PolyPid has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PolyPid has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 51.95 | 54.55 | |
| Return On Tangible Assets | (1.40) | (1.47) | |
| Return On Capital Employed | (2.55) | (2.67) | |
| Return On Assets | (1.40) | (1.47) | |
| Return On Equity | 13.09 | 13.75 |
Things to note about PolyPid performance evaluation
Checking the ongoing alerts about PolyPid for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PolyPid help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PolyPid generated a negative expected return over the last 90 days | |
| PolyPid has high historical volatility and very poor performance | |
| PolyPid has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PolyPid currently holds about 23.78 M in cash with (21.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| PolyPid has a frail financial position based on the latest SEC disclosures | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: PolyPid Ltd. Short Interest Update |
- Analyzing PolyPid's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PolyPid's stock is overvalued or undervalued compared to its peers.
- Examining PolyPid's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PolyPid's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PolyPid's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PolyPid's stock. These opinions can provide insight into PolyPid's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |